Write a note In the chart Compare Glossary API Get access

Pogosh CDS vs Isabel

Isabel Healthcare has been building differential diagnosis support since 1999. Its engine takes demographics plus free-text clinical features and returns a ranked differential across more than 10,000 conditions, flagging "don't miss" diagnoses. It is the closest architectural analogue to Pogosh in this market, and there are two things it does that Pogosh does not: it has two decades of published peer-reviewed validation, and it already runs an education product off the same engine that powers its clinical product. Pogosh did not originate that pattern.

FACTS VERIFIED AGAINST ISABEL HEALTHCARE SOURCES · AUGUST 2026

The difference is what comes back, not whether it reaches the chart

It would be easy — and wrong — to say Isabel is "just a lookup tool." It is not. Isabel Active Intelligence reads EMR notes with NLP and generates the differential inside the chart, Isabel is listed in the Cerner App Gallery, Epic sites can reach it by infobutton, and its API returns structured JSON. On integration, Isabel is genuinely embedded. The real difference is the shape of the answer. Isabel reads the note and hands back diagnoses — what this could be. Pogosh reads the same note and hands back the workup — the specific labs and imaging to order with their codes, who to route to and how urgently, what should escalate care, and a drafted note. Choosing between them is choosing which of those two questions is the one slowing you down.

Which one you want depends on the job

We would rather you picked the right tool than picked ours. These lists are meant to be used honestly.

Choose Isabel if…

  • Your unmet need is diagnostic breadth on a genuinely undifferentiated presentation. Isabel is a purpose-built differential generator across 10,000+ conditions; Pogosh is not trying to be one.
  • You must satisfy a P&T committee, risk management, med-legal review or procurement process that requires published peer-reviewed validation. Isabel has it going back two decades. Pogosh does not have it at all.
  • Cost per clinician is decisive. Isabel publishes individual pricing at $149 per YEAR — roughly $12–17 per month — which is a fundamentally different price point from Pogosh at $149–299 per MONTH.
  • You want a "don't miss" red-flag list attached to a differential.
  • You want a diagnosis-first tool rather than an orders-first one.

Choose Pogosh CDS if…

  • You need the workup rather than the differential — the specific labs, imaging, routing and escalation thresholds that follow.
  • You need output coded for a chart to act on, with LOINC and RadLex identifiers.
  • You want the recommendation to account for imaging and procedures already performed.
  • You want a note drafted from the same encounter.
  • You want to evaluate the API today without a sales conversation.

Side by side

Only rows that can be checked against a public source. Rows where Pogosh CDS is the weaker option are included on purpose.

Pogosh CDSIsabel
Primary jobWhat to order next for this patientWhat could this be — a ranked differential
What comes backOrderable items: named labs and imaging studies, each with the reason, plus routing and escalation thresholdsA ranked list of candidate diagnoses with "don't miss" flags, linked to evidence resources
Labs and imaging to orderYes — LOINC-coded labs and RadLex-coded imaging, ranked, accounting for what was already doneNot the output. Isabel identifies candidate diagnoses; selecting the workup remains with the clinician
Specialist and interventional routingYes — which specialty, how urgently, including interventional radiology options where they genuinely applyNot part of the output
Escalation criteriaYes — the specific findings that should escalate care, plus an emergency safety backstopRed-flag "don't miss" diagnoses are flagged within the differential
Reads the chart automaticallyYes — note or structured parameters in, workup outYes — Isabel Active Intelligence uses NLP on EMR notes to feed the differential; also Cerner App Gallery and Epic infobutton
Condition breadthFocused corpus built around workup and routing10,000+ conditions, all ages and specialties
Machine-readable codesLOINC, RadLex, ICD-10-CMStructured JSON, diagnosis-oriented
Developer APIYes — evaluation key issued directlyYes, documented and available since 2010; access is sales-gated rather than self-serve
Published individual pricing$149–299 per MONTH$149 per YEAR standard, $199 per YEAR premium (≈$12–17 per month)
Published peer-reviewed validationNone yet — partner program startingTwo decades of published studies on accuracy, impact and utility
Education product on the same engineYes — Clinical CrusaderYes — Isabel Clinical Educator, long established

On integration specifically: Isabel Active Intelligence applies NLP to EMR notes and can be fully embedded via the Isabel API, so this is not a case of one product being in the chart and the other outside it. Both are. They return different things once there.

Verified against Isabel Healthcare public sources in August 2026. Where a figure is not published by the vendor we say so rather than estimate. Products change — if something here is out of date or unfair, email signal@gighz.com and we will correct it.

Questions

Is Isabel cheaper than Pogosh CDS?

For an individual clinician, substantially — and it is important to compare the same unit. Isabel publishes individual pricing at $149 per year, about $12–17 per month. Pogosh is $149–299 per month, priced as a practice- or application-level API rather than a per-clinician reading seat. If your need is one clinician wanting a differential, Isabel is the far cheaper answer.

Pogosh says it powers an education game off the same engine. Is that unique?

No. Isabel has run Isabel Clinical Educator off its own diagnostic engine for years, so the pattern of one clinical engine serving both a production product and an education product is well established. What it demonstrates for Pogosh is that the API is real and general enough to drive more than one product — not that the idea is novel.

Which has better evidence behind it?

Isabel, clearly and by a wide margin. It has published peer-reviewed validation studies going back roughly two decades covering diagnostic accuracy, clinical impact and utility. Pogosh has no published validation; a clinical validation partner program is only now beginning. If published evidence is a requirement for you, that is a real and current gap.

The honest test is your own case.

Paste a real note and judge the reasoning yourself.